The effectiveness of decellularization protocols was further analyzed by quantifying the remaining DNA in grafts. The
TIANamp Genomic DNA Kit (Takara, China) was used to extract DNA from the samples of each group according to the manufacturer’s instruction. Then, the extracted DNA was quantified with BioDrop (BioLion, UK). Besides, the remnant DNA fragments were measured by the semi-quantitative agarose gel electrophoresis test.
A hydroxyproline quantification assay with
Hydroxyproline Assay Kit (Sigma) was performed to determine the total collagen content of each group according to the manufacturer’s instruction. This assay takes advantage of the characteristic that hydroxyproline is mainly limited to collagen and uses it as an indicator of total collagen content. The amount of total collagen was calculated according to the ratio of hydroxyproline to collagen, which was 1:7.69.
GAGs content of grafts in three groups was assessed using Dimethylmethylene Blue Assay Kit (GenMed) following the manufacturer’s instructions.
There are five replicate samples in each group in all quantitative tests, and the data are normalized to dry weight.
Lin S., He Y., Tao M., Wang A, & Ao Q. (2021). Fabrication and evaluation of an optimized xenogenic decellularized costal cartilage graft: preclinical studies of a novel biocompatible prosthesis for rhinoplasty. Regenerative Biomaterials, 8(6), rbab052.